Iridoid-phenylethanoic complex with antimicrobial action from Caucasian phlomis (Phlomis caucasica)

EA202593503A1Pending Publication Date: 2026-11-05AZERBAIJAN MEDICINAL UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
EA202593503
Authority / Receiving Office
EA · EA
Patent Type
Applications
Current Assignee / Owner
Filing Date
2025-12-11
Publication Date
2026-11-05
Estimated Expiration
2045-12-11

Smart Images

  • Figure 00000016_0000
    Figure 00000016_0000
  • Figure 00000017_0000
    Figure 00000017_0000
  • Figure 00000017_0001
    Figure 00000017_0001
Patent Text Reader

Abstract

The invention relates to medicine, more precisely to the field of pharmacy, namely to complexes of biologically active substances isolated from plant raw materials, having a broad spectrum of action, in particular to iridoid-phenylethanoid complexes with antimicrobial action. The essence of the invention lies in an iridoid-phenylethanoid complex with antimicrobial property from Caucasian comfrey, which contains: iridoid lamiid (C17H26O12) (methyl (1S,4aR,6S,7R,7aS)-4a,6,7-trihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate); forsythoside B (3,4-dihydroxy-β-phenylethoxy-O-[α-rhamnopyranosyl-(1→3)]-O-[β-apiofuranosyl-(1→6)]-4'-O-caffeoyl-β-glucopyranoside) and leucoseptoside B (3-hydroxy-4-methoxy-β-phenylethoxy-O-[α-rhamnopyranosyl-(1→3)]-O-[β-apiofuranosyl-(1→6)]-4'-O-feruloyl-β-glucopyranoside).The technical effect of the claimed invention consists in solving the stated problem and in analyzing and confirming the antimicrobial effectiveness of the obtained complex.
Need to check novelty before this filing date? Find Prior Art

Claims

Iridoid-phenylethanoid complex with antimicrobial property from Caucasian comfrey, containing: iridoid lamiid (C17H26O12), (methyl(1S,4aR,6S,7R,7aS)-4a,6,7-trihydroxy-7-methyl-1-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-1,5,6,7a-tetrahydrocyclopenta[c]pyran-4-carboxylate); forsythoside B (3,4-dihydroxy-β-phenylethoxy-O-[α-rhamnopyranosyl-(1→3)]-O-[β-apiofuranosyl-(1→6)]-4'-O-caffeoyl-β-glucopyranoside) and leucoseptoside B (3-hydroxy-4-methoxy-β-phenylethoxy-O-[α-rhamnopyranosyl-(1→3)]-O-[β-apiofuranosyl-(1→6)]-4'-O-feruloyl-β-glucopyranoside).